Brief: Telesis Bio And Cellibre Announce Collaboration To Optimize Development Of Future Bioxp Dbc Instrument
19/10/2022 14:03
Oct 19 (Reuters) - Codex DNA Inc DNAY.O :
* TELESIS BIO AND CELLIBRE ANNOUNCE COLLABORATION TO
OPTIMIZE
DEVELOPMENT OF FUTURE BIOXP® DBC INSTRUMENT
Source text for Eikon: ID:nGNX1mScj6
Further company coverage: DNAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview